Blood based biomarkers beyond genomics for lung cancer screening

被引：38
作者：
Hanash, Samir M. [1 ]
Ostrin, Edwin Justin [2 ]
Fahrmann, Johannes F. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA
来源：
TRANSLATIONAL LUNG CANCER RESEARCH | 2018年 / 7卷 / 03期
关键词：
Biomarkers; proteins; metabolites; autoantibodies; RISK PREDICTION MODEL; DOSE COMPUTED-TOMOGRAPHY; SERUM BIOMARKER; EARLY-DIAGNOSIS; PANEL; VALIDATION; PLASMA; ADENOCARCINOMA; IDENTIFICATION; METABOLOMICS;
D O I：
10.21037/tlcr.2018.05.13
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
While there is considerable interest at the present time in the development of so-called liquid biopsy approaches for cancer detection based notably on circulating tumor DNA, there are other types of potential biomarkers that show promise for lung cancer screening and early detection. Here we review approaches and some of the promising markers based on proteomics, metabolomics and the immune response to tumor antigens in the form of autoantibodies.
引用
收藏
页码：327 / 335
页数：9
相关论文
共 87 条
  • [1] Detecting the Presence and Progression of Premalignant Lung Lesions via Airway Gene Expression
    Beane, Jennifer
    Mazzilli, Sarah A.
    Tassinari, Anna M.
    Liu, Gang
    Zhang, Xiaohui
    Liu, Hanqiao
    Buncio, Anne Dy
    Dhillon, Samjot S.
    Platero, Suso J.
    Lenburg, Marc E.
    Reid, Mary E.
    Lam, Stephen
    Spira, Avrum E.
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (17) : 5091 - 5100
  • [2] A Multiplexed Serum Biomarker Immunoassay Panel Discriminates Clinical Lung Cancer Patients from High-Risk Individuals Found to be Cancer-Free by CT Screening
    Bigbee, William L.
    Gopalakrishnan, Vanathi
    Weissfeld, Joel L.
    Wilson, David O.
    Dacic, Sanja
    Lokshin, Anna E.
    Siegfried, Jill M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (04) : 698 - 708
  • [3] Establishment of a Multi-Analyte Serum Biomarker Panel to Identify Lymph Node Metastases in Non-small Cell Lung Cancer
    Borgia, Jeffrey A.
    Basu, Sanjib
    Faber, L. Penfield
    Kim, Anthony W.
    Coon, John S.
    Kaiser-Walters, Kelly A.
    Fhied, Cristina
    Thomas, Sherene
    Rouhi, Omid
    Warren, William H.
    Bonomi, Philip
    Liptay, Michael J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (03) : 338 - 347
  • [4] Clinical validation of an autoantibody test for lung cancer
    Boyle, P.
    Chapman, C. J.
    Holdenrieder, S.
    Murray, A.
    Robertson, C.
    Wood, W. C.
    Maddison, P.
    Healey, G.
    Fairley, G. H.
    Barnes, A. C.
    Robertson, J. F. R.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (02) : 383 - 389
  • [5] Inflammatory Cytokines and Lung Cancer Risk in 3 Prospective Studies
    Brenner, Darren R.
    Fanidi, Anouar
    Grankvist, Kjell
    Muller, David C.
    Brennan, Paul
    Manjer, Jonas
    Byrnes, Graham
    Hodge, Allison
    Severi, Gianluca
    Giles, Graham G.
    Johansson, Mikael
    Johansson, Mattias
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2017, 185 (02) : 86 - 95
  • [6] The metabolomic detection of lung cancer biomarkers in sputum
    Cameron, Simon J. S.
    Lewis, Keir E.
    Beckmann, Manfred
    Allison, Gordon G.
    Ghosal, Robin
    Lewis, Paul D.
    Mur, Luis A. J.
    [J]. LUNG CANCER, 2016, 94 : 88 - 95
  • [7] Rethinking Autoantibody Signature Panels for Cancer Diagnosis
    Campa, Michael J.
    Gottlin, Elizabeth B.
    Herndon, James E., II
    Patz, Edward F., Jr.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (06) : 1011 - 1014
  • [8] Carozzi FM, 2016, EPIDEMIOL PREV, V40, P56, DOI 10.19191/EP16.1S1.P056.031
  • [9] Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study
    Carreras-Torres, Robert
    Johansson, Mattias
    Haycock, Philip C.
    Wade, Kaitlin H.
    Relton, Caroline L.
    Martin, Richard M.
    Smith, George Davey
    Albanes, Demetrius
    Aldrich, Melinda C.
    Andrew, Angeline
    Arnold, Susanne M.
    Bickeboeller, Heike
    Bojesen, Stig E.
    Brunnstrom, Hans
    Manjer, Jonas
    Brueske, Irene
    Caporaso, Neil E.
    Chen, Chu
    Christiani, David C.
    Christian, W. Jay
    Doherty, Jennifer A.
    Duell, Eric J.
    Field, John K.
    Davies, Michael P. A.
    Marcus, Michael W.
    Goodman, Gary E.
    Grankvist, Kjell
    Haugen, Aage
    Hong, Yun-Chul
    Kiemeney, Lambertus A.
    van der Heijden, Erik H. F. M.
    Kraft, Peter
    Johansson, Mikael B.
    Lam, Stephen
    Landi, Maria Teresa
    Lazarus, Philip
    Le Marchand, Loic
    Liu, Geoffrey
    Melander, Olle
    Park, Sungshim L.
    Rennert, Gad
    Risch, Angela
    Haura, Eric B.
    Scelo, Ghislaine
    Zaridze, David
    Mukeriya, Anush
    Savic, Milan
    Lissowska, Jolanta
    Swiatkowska, Beata
    Janout, Vladimir
    [J]. PLOS ONE, 2017, 12 (06):
  • [10] EarlyCDTA®-Lung test: improved clinical utility through additional autoantibody assays
    Chapman, Caroline J.
    Healey, Graham F.
    Murray, Andrea
    Boyle, Peter
    Robertson, Chris
    Peek, Laura J.
    Allen, Jared
    Thorpe, Alison J.
    Hamilton-Fairley, Geoffrey
    Parsy-Kowalska, Celine B.
    MacDonald, Isabel K.
    Jewell, William
    Maddison, Paul
    Robertson, John F. R.
    [J]. TUMOR BIOLOGY, 2012, 33 (05) : 1319 - 1326
123456789